Emergent BioSolutions (NYSE:EBS) Board Announces Stock Repurchase Plan
Emergent BioSolutions (NYSE:EBS – Get Free Report) declared that its board has approved a share repurchase plan on Monday, March 31st, RTT News reports. The company plans to buyback $50.00 million in shares. This buyback authorization permits the biopharmaceutical company to purchase up to 19% of its stock through open market purchases. Stock buyback plans […]
Emergent BioSolutions (NYSE:EBS – Get Free Report) declared that its board has approved a share repurchase plan on Monday, March 31st, RTT News reports. The company plans to buyback $50.00 million in shares. This buyback authorization permits the biopharmaceutical company to purchase up to 19% of its stock through open market purchases. Stock buyback plans […]
